Has Leonel Vance, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,071 in general payments to Leonel Vance, MD across 188 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leonel Vance, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leonel Vance, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leonel Vance, MD

Interventional Pain Medicine · Madison, MSNPI 1669507943

Payments from drug & device makers

What this record shows

This record is dominated by gifts: $13,931 of the $21,071 with a category attached, or 66.1%. AbbVie accounts for 66.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $15,278 and has fallen 85.9% since, to $2,160 in 2025. Among interventional pain medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,071in general payments, 2019–2025

Across 188 payments — averaging $112.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$14K
Abbott$3K
Spinal Simplicity, LLC$1K
Medtronic$683
Stryker$480
Collegium Pharmaceutical, Inc.$358
plus $2K from 20 others

What the payments were for

Travel & lodging$1,1796%
Food & beverage$5,91928%
Education$420%
Gifts$13,93166%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	1	$13,931
Abbott	66	$2,989
Spinal Simplicity, LLC	14	$1,072
Medtronic	18	$683
Stryker	2	$480
Collegium Pharmaceutical, Inc.	23	$358
Biotronik NRO, Inc.	5	$333
Si-bone, Inc.	2	$252
Avanir Pharmaceuticals, Inc.	1	$125
GRT US Holding, Inc.	2	$110
Arbor Pharmaceuticals, Inc.	6	$100
Daiichi Sankyo Inc.	5	$86
Biodelivery Sciences International, Inc.	6	$82
Teva Pharmaceuticals USA, Inc.	5	$80
Hikma Pharmaceuticals USA	4	$73
Takeda Pharmaceuticals U.S.A., Inc.	11	$56
Shionogi Inc	3	$46
Pfizer	3	$44
Biohaven Pharmaceuticals, Inc.	2	$37
Assertio Therapeutics, Inc.	2	$28
AstraZeneca	2	$26
Amgen	1	$22
Kowa Pharmaceuticals America, Inc.	1	$17
Nalu Medical, Inc.	1	$17
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$13
Lilly USA, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,071 in reported general payments places this provider in the 95th percentile of 24 interventional pain medicine providers in Mississippi.

See all interventional pain medicine providers in Mississippi →

Medicare billing

Part B allowed, 2024

$383,604

Medicare patients

397

Services billed

4,842

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methadone Hcl	116	$7,070

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Madison

Madelyn CraigMadison$5K
Eric PearsonMeridian$19K
Charles MartinMeridian$18K
Matthew BlanchardGulfport$10K
Kenneth StaggsMeridian$5K
John LutzJackson$5K
Michael SteuerSouthaven$4K
Kelly ColemanVancleave$4K
Carol HarrisMeridian$4K
Thomas YearwoodPascagoula$3K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →